This inventor holds 11 USPTO granted patents and 4 EPO patents. Top assignees: Taivex Therapeutics Corporation, Development Center of Biotechnology, Ribapharm Inc.. Active years: 2002-2021.
Location History:
- Costa Mesa, CA (US) (2002)
- Newport Beach, CA (US) (2004 - 2021)
Company Filing History:
6 out of 8 
2 out of 3 
2 out of 5 
Years Active: 2002-2021
Title: Innovations and Contributions of Johnson Lau
Introduction
Johnson Lau is a prominent inventor based in Newport Beach, CA. He has made significant contributions to the field of biotechnology, holding a total of 11 patents. His work primarily focuses on the modulation of HEC1 activity, which has implications for cancer treatment.
Latest Patents
Among his latest patents are the "Modulators of HEC1 activity and methods therefor." These patents detail compounds, compositions, and methods for modulating the Hec1/Nek2 interaction. Such compounds are designed to disrupt the binding between Nek2 and Hec1, potentially serving as chemotherapeutic agents for neoplastic diseases.
Career Highlights
Johnson Lau has worked with notable companies in the biotechnology sector, including Taivex Therapeutics Corporation and Ribapharm Inc. His experience in these organizations has allowed him to develop innovative solutions that address critical health challenges.
Collaborations
Throughout his career, Johnson has collaborated with esteemed colleagues such as Zhi Hong and Jiann-Jyh Huang. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Johnson Lau's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and therapeutic development.